Patents by Inventor Donald Wesson

Donald Wesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating anxiety related disorders
    Patent number: 8012958
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: September 6, 2011
    Assignee: Hythlam, Inc.
    Inventors: Sanjay Sabnani, Donald Wesson
  • Methods for Treating Anxiety Related Disorders
    Publication number: 20080280885
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
    Type: Application
    Filed: April 7, 2006
    Publication date: November 13, 2008
    Applicant: Hythiam, INC.
    Inventors: Sanjay Sabnani, Donald Wesson
  • Methods for the Treatment of Substance Abuse and Dependence
    Publication number: 20080255097
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. More specifically, the present invention relates to methods of and compositions for treating and relieving symptoms associated with substance abuse and withdrawal. The present invention relates to methods of and compositions for treating and relieving symptoms associated with addiction to antidepressants, opiates, nicotine or marijuana. In one method, a patient is treated with a composition that directly or indirectly modulates GABAA by modulating the expression of the GABAA receptor a4 subunit.
    Type: Application
    Filed: April 7, 2006
    Publication date: October 16, 2008
    Applicant: Hythiam, Inc.
    Inventors: Sanjay Sabnani, Donald Wesson, Joseph Dunn